Glucagon-Like-Peptide-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health. Emerging research suggests that GLP1-Receptor Agonists could be supportive in managing inflammatory symptoms associated with Mast Cell Activation Syndrome (MCAS). Although research is currently limited, Anna talks about what we know so far and her experience with clients taking these drugs in clinical practice.
Website: http://annamarsh.co.uk/
Instagram: https://www.instagram.com/anna_marsh_nutrition/
Research Paper: https://www.sciencedirect.com/science/article/abs/pii/S0002962925011061
Take the Fatigue Recovery Quiz: https://app.annamarsh.co.uk/quiz
New Nurturing Resilience Membership: https://annamarsh.co.uk/nurturing-resilience/
Shownotes Grief is an inevitable part of healing. In this episode, Anna talks about her own experience of grief in her healing journey. She...
This episode covers the topic of rest and chronic fatigue, specifically, how to rest better! A while back Anna surveyed her instagram followers and...
Shownotes Proper thyroid screening is important to rule thyroid imbalances in or out on your fatigue and health recovery journey. In this episode Anna...